Taiwan · Delayed Price · Currency is TWD GeneReach Biotechnology Statistics
Total Valuation
TPEX:4171 has a market cap or net worth of TWD 994.21 million. The enterprise value is 820.50 million.
| Market Cap | 994.21M |
| Enterprise Value | 820.50M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4171 has 57.30 million shares outstanding. The number of shares has decreased by -0.49% in one year.
| Current Share Class | 57.30M |
| Shares Outstanding | 57.30M |
| Shares Change (YoY) | -0.49% |
| Shares Change (QoQ) | -2.22% |
| Owned by Insiders (%) | 17.16% |
| Owned by Institutions (%) | n/a |
| Float | 39.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.18 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | 786.56 |
| P/OCF Ratio | 72.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 144.84, with an EV/FCF ratio of 649.13.
| EV / Earnings | n/a |
| EV / Sales | 3.45 |
| EV / EBITDA | 144.84 |
| EV / EBIT | n/a |
| EV / FCF | 649.13 |
Financial Position
The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.37.
| Current Ratio | 2.41 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 37.66 |
| Debt / FCF | 168.78 |
| Interest Coverage | -10.17 |
Financial Efficiency
Return on equity (ROE) is -7.60% and return on invested capital (ROIC) is -11.65%.
| Return on Equity (ROE) | -7.60% |
| Return on Assets (ROA) | -3.70% |
| Return on Invested Capital (ROIC) | -11.65% |
| Return on Capital Employed (ROCE) | -8.10% |
| Weighted Average Cost of Capital (WACC) | 5.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.26 |
| Inventory Turnover | 1.61 |
Taxes
| Income Tax | -3.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.81% in the last 52 weeks. The beta is 0.38, so TPEX:4171's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -12.81% |
| 50-Day Moving Average | 17.36 |
| 200-Day Moving Average | 19.04 |
| Relative Strength Index (RSI) | 50.53 |
| Average Volume (20 Days) | 107,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4171 had revenue of TWD 238.08 million and -43.09 million in losses. Loss per share was -0.75.
| Revenue | 238.08M |
| Gross Profit | 173.30M |
| Operating Income | -53.38M |
| Pretax Income | -49.82M |
| Net Income | -43.09M |
| EBITDA | -6.15M |
| EBIT | -53.38M |
| Loss Per Share | -0.75 |
Balance Sheet
The company has 395.82 million in cash and 213.34 million in debt, with a net cash position of 182.48 million or 3.18 per share.
| Cash & Cash Equivalents | 395.82M |
| Total Debt | 213.34M |
| Net Cash | 182.48M |
| Net Cash Per Share | 3.18 |
| Equity (Book Value) | 581.48M |
| Book Value Per Share | 10.33 |
| Working Capital | 280.30M |
Cash Flow
In the last 12 months, operating cash flow was 13.63 million and capital expenditures -12.37 million, giving a free cash flow of 1.26 million.
| Operating Cash Flow | 13.63M |
| Capital Expenditures | -12.37M |
| Depreciation & Amortization | 47.23M |
| Net Borrowing | -46.52M |
| Free Cash Flow | 1.26M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 72.79%, with operating and profit margins of -22.42% and -18.10%.
| Gross Margin | 72.79% |
| Operating Margin | -22.42% |
| Pretax Margin | -20.93% |
| Profit Margin | -18.10% |
| EBITDA Margin | -2.58% |
| EBIT Margin | -22.42% |
| FCF Margin | 0.53% |
Dividends & Yields
TPEX:4171 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.49% |
| Shareholder Yield | 0.49% |
| Earnings Yield | -4.33% |
| FCF Yield | 0.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2023. It was a forward split with a ratio of 1.25.
| Last Split Date | Jul 28, 2023 |
| Split Type | Forward |
| Split Ratio | 1.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |